Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally?

By David Jagielski, CPA – Apr 27, 2026 at 4:00PM ESTKey PointsMarijuana rescheduling is positive news for the industry, but it may not necessarily help Canopy Growth.Renewed hopes for marijuana reform in the U.S. have been giving the stock a boost of late. The company has gotten smaller in an effort to reduce spending, but its losses remain significant.Canopy Growth (CGC +1.27%) has been rallying lately, as excitement has been growing in the marijuana industry. The U.S. government recently announced it rescheduled medical marijuana from a Schedule I substance to Schedule III, and that news has helped give Canopy Growth's stock a boost. So far in 2026, the pot stock is up around just 2%, but it's been picking up steam over the past month, rallying more than 30%. With the stock taking a beating in recent years, could it be overdue for more of a rally, and is news around marijuana rescheduling in the U.S. just what it needs for its share price to soar even higher? Image source: Getty Images. Canopy Growth's stock has lost nearly all of its value in five years Five years ago, Canopy Growth's market cap was around $11 billion. Hopes were high that the U.S. might be on the cusp of significant reform with the Democrats controlling both the House and Senate. However, nothing ultimately happened. Canopy Growth's results remained poor, and the company scaled down its operations, turning to an "asset-light" model in an effort to curb spending. Today, its market cap is right around $500 million. That's a 95% decline in value. Things haven't gone Canopy Growth's way at all, and investors have felt the pain. That's why the recent positive news around marijuana rescheduling in the U.S. may have given them a reason to finally feel optimistic about the pot stock once again. The problem is that it simply isn't a better buy. ExpandNASDAQ: CGCCanopy GrowthToday's Change(1.27%) $0.01Current Price$1.20Key Data PointsMarket Cap$505MDay's Range$1.15 - $1.2152wk Range$0.84 - $2.38Volume14MAvg Vol11MGross Margin18.25% Rescheduling might help the cannabis industry, but it doesn't make Canopy Growth a better stock to buy The immediate effects of marijuana rescheduling are that it will lower tax bills for multi-state operators in the U.S., but it won't have any positive impact on Canopy Growth. Since it's still operating in Canada and doesn't have a presence in the U.S., and likely won't until legalization takes place, it's effectively in the same position it was before. Rescheduling may be positive for the industry as a whole, but it doesn't mean that legalization will happen anytime soon, which is ultimately what Canopy Growth investors are eagerly awaiting. Canopy Growth's business has shrunk in size over the years, but its losses remain significant, totaling 327 million Canadian dollars over the trailing 12 months. The stock isn't any safer of an investment on rescheduling news, and investors should be careful not to assume otherwise. It may have gone on for the rally along with other pot stocks in the past month, but it's likely to be a short-lived boost. Read NextApr 24, 2026 •By Reuben Gregg BrewerCanopy Growth Is Rallying Again.

But Is It a Dead Cat Bounce?Apr 22, 2026 •By Thomas NielFrom $500 to $1: Is Canopy Growth a Dead Stock Walking or the Ultimate Turnaround Play?Mar 30, 2026 •By David Jagielski, CPAThinking About Buying Canopy Growth Stock?

You May Want to Wait for This to Happen FirstApr 27, 2026 •By David Jagielski, CPAMarijuana Rescheduling Has Arrived. Don't Make This MistakeApr 27, 2026 •By Adam LevyThe First Blockbuster Artificial Intelligence IPO of 2026 Is Almost Here. Here's Why I'm Staying Away.Apr 27, 2026 •By Keith NoonanWhy Verizon Stock Gained TodayAbout the AuthorDavid Jagielski, CPA, has been a contributing Motley Fool stock market analyst covering healthcare, consumer staples, consumer discretionary, and technology stocks since 2017. David has more than 10 years of experience in finance roles across businesses of different sizes and sectors. He holds a Certified Public Accountant designation in Canada.TMFdjagielskiStocks MentionedCanopy GrowthNASDAQ: CGC$1.20(+1.27%)+$0.02*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.